Meeting the challenge of antimicrobial resistance (AMR) in cirrhosis: the invisible threat that lies within
Virtualhttps://twitter.com/EASLedu/status/1595078674197381125
Loading view.
Hepatitis C and Injection Drug Use
Virtualhttps://twitter.com/NYSDOH_CEI/status/1594707350342057984
Diet, Liver Diseases, Liver Cancer: Prevention from the Source
Virtualhttps://twitter.com/HepatomaRes/status/1594572896885952522
First Annual NAFLD & NASH PC Summit
Virtualhttps://twitter.com/nashnetca/status/1575083169912885248
$25 – $50
Proposed Perinatal Hepatitis C Testing Recommendations
Virtualhttps://twitter.com/cdchep/status/1595419422898163712
Pediatric Liver Disease and Transplantation Symposium
Virtualhttps://twitter.com/columbiacancer/status/1596171478265122821
Non-invasive Assessment of Clinically Significant Portal Hypertension
Virtualhttps://twitter.com/AASLDtweets/status/1602120477014736896
A New Era of NASH Management
Virtualhttps://twitter.com/LiverSaver/status/1600867204282855425
Hepatitis C Update- Empire Liver Foundation
Virtualhttps://twitter.com/LiverEmpire/status/1602423148724588544
ALF Advocacy Update
Virtualhttps://twitter.com/liverUSA/status/1595103086636417024
IDWeek 2023 Industry Partner Preview Event
Virtualhttps://twitter.com/IDWeek2022/status/1600946592252661760
Ask the Experts – Why a Clinical Trial Might be Right For You
Virtualhttps://twitter.com/liverUSA/status/1597340422762008577